首页> 外文期刊>慢性疾病与转化医学(英文) >Screening for candidate genes related to breast cancer with cDNA microarray analysis
【24h】

Screening for candidate genes related to breast cancer with cDNA microarray analysis

机译:利用cDNA微阵列分析筛选与乳腺癌相关的候选基因

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: The aim of this study was to reveal the exact changes during the occurrence of breast cancer to explore significant new and promising genes or factors related to this disease. Methods: We compared the gene expression profiles of breast cancer tissues with its uninvolved normal breast tissues as controls using the cDNA microarray analysis in seven breast cancer patients. Further, one representative gene, named IFI30, was quanti-tatively analyzed by real-time PCR to confirm the result of the cDNA microarray analysis. Results: A total of 427 genes were identified with significantly differential expression, 221 genes were up-regulated and 206 genes were down-regulated. And the result of cDNA microarray analysis was validated by detection of IFI30 mRNA level changes by real-time PCR. Genes for cell proliferation, cell cycle, cell division, mitosis, apoptosis, and immune response were enriched in the up-regulated genes, while genes for cell adhesion, proteolysis, and transport were significantly enriched in the down-regulated genes in breast cancer tissues compared with normal breast tissues by a gene ontology analysis. Conclusion: Our present study revealed a range of differentially expressed genes between breast cancer tissues and normal breast tissues, and provide candidate genes for further study focusing on the pathogenesis and new biomarkers for breast cancer. Copyright © 2015, Chinese Medical Association Production. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
机译:目的:本研究的目的是揭示乳腺癌发生过程中的确切变化,以探索与该疾病相关的重要的新的有前途的基因或因素。 方法:我们使用cDNA微阵列分析比较了7例乳腺癌患者的乳腺癌组织及其未累及的正常乳腺癌组织的基因表达谱。此外,通过实时PCR定量分析了一种代表性基因,命名为IFI30,以确认cDNA微阵列分析的结果。 结果:共鉴定到427个表达差异显着的基因,其中221个基因上调,而206个基因下调。通过实时PCR检测IFI30 mRNA水平的变化,验证了cDNA微阵列分析的结果。上调基因丰富了细胞增殖,细胞周期,细胞分裂,有丝分裂,凋亡和免疫反应的基因,而乳腺癌组织中下调基因显着丰富了细胞粘附,蛋白水解和转运的基因。通过基因本体分析与正常乳腺组织进行比较。 结论:我们的当前研究揭示了乳腺癌组织和正常乳腺癌组织之间一系列差异表达的基因,并为进一步研究乳腺癌的发病机理和新的生物标志物提供了候选基因。 版权所有©2015,中华医学会制作。由Elsevier BV代表KeAi Communications Co.,Ltd.制作和托管。这是CC BY-NC-ND许可下的开放获取文章(http://creativecommons.org/licenses/by-nc-nd/4.0/ )。

著录项

  • 来源
    《慢性疾病与转化医学(英文)》 |2015年第002期|65-72|共8页
  • 作者单位

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

    Department of Breast Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:47:17
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号